BD 1063 dihydrochlorideσ1 receptor antagonist,potent and selective CAS# 206996-13-6 |
- Leupeptin, Microbial
Catalog No.:BCC1217
CAS No.:103476-89-7
- AEBSF.HCl
Catalog No.:BCC1219
CAS No.:30827-99-7
- PMSF
Catalog No.:BCC1229
CAS No.:329-98-6
- Nafamostat Mesylate(FUT-175)
Catalog No.:BCC1228
CAS No.:82956-11-4
- Aprotinin
Catalog No.:BCC1220
CAS No.:9087-70-1
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 206996-13-6 | SDF | Download SDF |
| PubChem ID | 11617161 | Appearance | Powder |
| Formula | C13H20Cl4N2 | M.Wt | 346.13 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | H2O : ≥ 50 mg/mL (144.46 mM) *"≥" means soluble, but saturation unknown. | ||
| Chemical Name | 1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine;dihydrochloride | ||
| SMILES | CN1CCN(CC1)CCC2=CC(=C(C=C2)Cl)Cl.Cl.Cl | ||
| Standard InChIKey | NXFDBTLQOARIMH-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C13H18Cl2N2.2ClH/c1-16-6-8-17(9-7-16)5-4-11-2-3-12(14)13(15)10-11;;/h2-3,10H,4-9H2,1H3;2*1H | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | σ1 receptor antagonist, approximately 50-fold selective over σ2 sites and ≥100-fold selective over opioid, PCP, muscarinic, dopamine, α1, α2, β adrenoceptor, 5-HT1 and 5-HT2 receptors. Prevents hyperlocomotion following cocaine administration in mice. |
BD 1063 dihydrochloride Dilution Calculator
BD 1063 dihydrochloride Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.8891 mL | 14.4454 mL | 28.8909 mL | 57.7818 mL | 72.2272 mL |
| 5 mM | 0.5778 mL | 2.8891 mL | 5.7782 mL | 11.5564 mL | 14.4454 mL |
| 10 mM | 0.2889 mL | 1.4445 mL | 2.8891 mL | 5.7782 mL | 7.2227 mL |
| 50 mM | 0.0578 mL | 0.2889 mL | 0.5778 mL | 1.1556 mL | 1.4445 mL |
| 100 mM | 0.0289 mL | 0.1445 mL | 0.2889 mL | 0.5778 mL | 0.7223 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
BD 1063 dihydrochloride is an antagonist of σ-1 receptor with Ki value of 9.15 nM [1].
σ-receptor is a type of opioid receptor. There are two subtypes of σ-receptor: σ-1 and σ-2.σ-1 receptor plays an important role in stimulating dopamine release and modulating the actions of cocaine [2].
BD 1063 dihydrochloride is a σ-1 receptor antagonist with Ki values of 9.15 and 449 nM for σ-1 receptor and σ-2 receptor, respectively. BD1063 reduced the dystonia induced by haloperidol and di-o-tolylguanidine (DTG) in a dose-dependent way [1].
In mice, BD1063 inhibited up-regulation of fra-2 and σ-1 receptor induced by cocaine in whole brain, cortex and striatum [2]. In mice, BD1063 significantly inhibited convulsions, lethality and locomotor stimulatory effects induced by cocaine [3]. In two excessive drinking rat models, BD-1063 reduced ethanol self-administration in a dose-dependent way and inhibited the expression of σ-1 receptor in the nucleus accumbens [4]. In mice, BD-1063 reversed thermal (radiant heat) hyperalgesia and inflammatory mechanical (paw pressure) in a dose-dependent way. However, BD-1063 had no effect on thermal hyperalgesia in σ1 knockout (σ1-KO) mice. These results suggested that σ1 receptor played an important role in inflammatory hyperalgesia [5].
References:
[1]. Matsumoto RR, Bowen WD, Tom MA, et al. Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism. Eur J Pharmacol, 1995, 280(3): 301-310.
[2]. Liu Y, Chen GD, Lerner MR, et al. Cocaine up-regulates Fra-2 and sigma-1 receptor gene and protein expression in brain regions involved in addiction and reward. J Pharmacol Exp Ther, 2005, 314(2): 770-779.
[3]. Matsumoto RR, McCracken KA, Friedman MJ, et al. Conformationally restricted analogs of BD1008 and an antisense oligodeoxynucleotide targeting sigma1 receptors produce anti-cocaine effects in mice. Eur J Pharmacol, 2001, 419(2-3): 163-174.
[4]. Sabino V, Cottone P, Zhao Y, et al. The sigma-receptor antagonist BD-1063 decreases ethanol intake and reinforcement in animal models of excessive drinking. Neuropsychopharmacology, 2009, 34(6): 1482-1493.
[5]. Tejada MA, Montilla-García A, Sánchez-Fernández C, et al. Sigma-1 receptor inhibition reverses acute inflammatory hyperalgesia in mice: role of peripheral sigma-1 receptors. Psychopharmacology (Berl), 2014, 231(19): 3855-3869.
- Methysticin
Catalog No.:BCN2306
CAS No.:20697-20-5
- Tariquidar
Catalog No.:BCC3625
CAS No.:206873-63-4
- Vincristine sulfate
Catalog No.:BCN2542
CAS No.:2068-78-2
- 3,7-Di-O-methylquercetin
Catalog No.:BCN6486
CAS No.:2068-02-2
- Pedatisectine F
Catalog No.:BCN4902
CAS No.:206757-32-6
- Ecliptasaponin D
Catalog No.:BCN2760
CAS No.:206756-04-9
- Cannabichromene
Catalog No.:BCN4901
CAS No.:20675-51-8
- Pasiniazid
Catalog No.:BCC3835
CAS No.:2066-89-9
- 7-O-Methylporiol
Catalog No.:BCN3948
CAS No.:206560-99-8
- Carmichaenine E
Catalog No.:BCN7730
CAS No.:2065228-63-7
- Carmichaenine D
Catalog No.:BCN7732
CAS No.:2065228-62-6
- Carmichaenine C
Catalog No.:BCN7731
CAS No.:2065228-61-5
- Neosperidin dihydrochalcone
Catalog No.:BCN5016
CAS No.:20702-77-6
- Norlichexanthone
Catalog No.:BCN4903
CAS No.:20716-98-7
- Fustin
Catalog No.:BCN4904
CAS No.:20725-03-5
- TB 21007
Catalog No.:BCC7510
CAS No.:207306-50-1
- Methyl sinapate
Catalog No.:BCN4675
CAS No.:20733-94-2
- 1,8-Bis(dimethylamino)naphtalene
Catalog No.:BCC8429
CAS No.:20734-58-1
- Saikosaponin C
Catalog No.:BCN1087
CAS No.:20736-08-7
- Saikosaponin A
Catalog No.:BCN1086
CAS No.:20736-09-8
- Dihydrosinapylalcohol
Catalog No.:BCN6542
CAS No.:20736-25-8
- 3-Bromocytisine
Catalog No.:BCC7705
CAS No.:207390-14-5
- MR 16728 hydrochloride
Catalog No.:BCC6684
CAS No.:207403-36-9
- Arteannuin L
Catalog No.:BCN4905
CAS No.:207446-89-7
Cocaine up-regulates Fra-2 and sigma-1 receptor gene and protein expression in brain regions involved in addiction and reward.[Pubmed:15879001]
J Pharmacol Exp Ther. 2005 Aug;314(2):770-9.
Sigma receptors have recently been implicated in the actions of cocaine, and antagonists of these receptors prevent many acute and subchronic cocaine effects. A previous study revealed that the immediate early gene fra-2 is up-regulated after cocaine administration, and this effect is prevented by the sigma-1 receptor antagonist BD1063 [1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine]. In the present study, the effects of cocaine and BD1063 on the expression of six fos and jun genes were evaluated in mouse brains using cDNA microarrays. Several of these genes were altered by cocaine, but only the alteration in fra-2 was prevented by BD1063. The time courses of fra-2 and sigma-1 receptor gene and protein expression in different brain regions were also determined. Cocaine up-regulated fra-2, which was followed by a later up-regulation of sigma-1 receptors. The cocaine-induced up-regulation of fra-2 and sigma-1 receptor genes and proteins were detected in whole brain, striatum, and cortex, but not in cerebellum. All of these cocaine-induced effects were prevented by BD1063. The interaction between cocaine, fra-2, and sigma-1 receptors involves brain regions that are established components of the neural circuit for reward, suggesting that they may contribute to the enduring changes that underlie the cellular basis of drug abuse.
Novel sigma receptor ligands attenuate the locomotor stimulatory effects of cocaine.[Pubmed:9988120]
Eur J Pharmacol. 1999 Jan 15;365(1):35-8.
Cocaine interacts with sigma receptors, suggesting that these sites are important for many of its behavioral effects. Therefore, two novel sigma receptor ligands, BD1008 (N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylamine) and BD1063 (1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine), were evaluated for their ability to attenuate cocaine-induced locomotor activity. Receptor binding studies showed that BD1008 and BD1063 have nanomolar affinities for sigma1 and sigma2 sites, but a 250-fold or lower affinity for nine other receptors, making them among the most selective sigma receptor ligands identified. In behavioral studies, pretreatment of mice with BD1008 or BD1063 produced a two-fold increase in the ED50 for the locomotor stimulatory effects of cocaine. These results suggest that sigma receptors are involved in the behavioral effects of cocaine.
Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism.[Pubmed:8566098]
Eur J Pharmacol. 1995 Jul 14;280(3):301-10.
The novel sigma receptor ligands, N(-)[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(dimethylamino)ethylamine (BD1047) and 1(-)[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine (BD1063), were characterized in rats using binding assays and behavioral studies. In radioligand binding studies, the novel ligands showed marked selectivity for sigma binding sites, generally having a 100-fold or better affinity for sigma sites compared to nine other tested receptors (opiate, phencyclidine, muscarinic, dopamine, alpha 1-, alpha 2-, beta-adrenoceptor, 5-HT1, 5-HT2); the only exception was the affinity of BD1047 for beta-adrenoceptors. Competition assays further revealed that the drugs interacted with both sigma 1 and sigma 2 binding sites. Although both drugs had preferential affinities for sigma 1 sites, BD1047 exhibited a higher affinity for sigma 2 sites than BD1063. In behavioral studies, BD1047 and BD1063 had no effects on their own when unilaterally microinjected into the red nucleus of rats, but both compounds attenuated the dystonia produced by the high affinity sigma ligands, di-o-tolylguanidine (DTG) and haloperidol. BD1047 and BD1063 dose-dependently attenuated the dystonia produced by DTG, suggesting a receptor-mediated mechanism, and the dose curve for DTG was shifted to the right in the presence of the novel ligands. BD1047 and BD1063 appear to act as antagonists at sigma sites and may represent promising new tools for probing other functional effects associated with sigma binding sites.
